Concepedia

Plasma Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1): An Independent Predictor of Poor Response to Cardiac Resynchronization Therapy

José Marı́a Tolosana, Marta Sitges, Antonio Berruezo, Victoria Delgado, Bárbara Vidal, David Tamborero, Manel Morales, Montserrat Batlle, Eulàlia Roig, M. Castel,

European Journal of Heart Failure · 2010 · 18 citations · 28 references

DOIFull text

Open access

Abstract

TIMP-1 is an independent predictor of non-response in patients treated with CRT.

References

28

Matrix metalloproteinases and their inhibitors in connective tissue remodeling

J. Frederick Woessner · The FASEB Journal · 1991 · 3.3K citations · Full text

Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

Sonia S. Anand, Shofiqul Islam, Annika Rosengren et al. · European Heart Journal · 2008 · 906 citations

Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association

European Heart Journal · 2007 · 901 citations · Full text

, , +25

[Guidelines for cardiac pacing and cardiac resynchronization therapy].

Panos Vardas, Angelo Auricchio, Jean‐Jacques Blanc et al. · PubMed · 2008 · 551 citations

, , +3

Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.

Jay N. Cohn, Gary R. Johnson, Ralph Shabetai et al. · PubMed · 1993 · 533 citations